

THE COMPARATIVE
ROLES OF
ELECTRON MICROSCOPY AND IMMUNOHISTOCHEMISTRY
IN THE DIAGNOSIS OF POORLY DIFFERENTIATED SARCOMAS
Marco Santucci,
Alessandro Franchi and Camilla E. Comm
Institute of Anatomic Pathology, University of Florence Medical
School, Florence, Italy
Object of the Study
The histologic typing of soft tissue sarcomas is generally feasible
when dealing with well or moderately differentiated tumors, such
as biphasic synovial sarcoma, fibrosarcoma, liposarcoma or extraskeletal
bone and cartilage tumors, which are characterized by a typi-cal
morphologic profile. The basic immunohistochemical staining patterns
of the different types of well/moderately differentiated sarcomas
are similarly well-established. Con-versely, poorly differentiated
soft tissue sarcomas quite often represent a difficult diagnostic
task, in large part due to the lack of specificity of diagnostic
histologic and immunohis-tochemical criteria. The aim of our study
was to investigate the comparative roles of elec-tron microscopy
and immunohistochemistry in the proper identification of poorly
differenti-ated, spindle cell and pleomorphic soft tissue sarcomas.
Materials & Methods
We investigated 34 cases of poorly differentiated, spindle cell
and pleomorphic sar-comas arising in deep soft tissues (excluding
the retroperitoneum) of adult patients ob-served in our Institution
in the last five years. This series represents the 13.4% of the
total amount of soft tissue sarcomas observed in the same period
of time (253 cases). Eighteen cases were investigated by means
of immunohistochemistry and electron microscopy from the beginning
while, in 16 cases, the patientswho had already underwent
a biopsy or a surgical procedure in another institutionwere
hospitalized to excise the tumor or to cure a recurrence. In these
cases, we were initially able to study only hematoxylin &
eosin stained slides, due to the unavailability of material for
immunohistochemical or submicro-scopic investigations. The diagnosis
made on hematoxylin & eosin stained sections was successively
compared with that formulated following the more exhaustive study
per-formed on the excised specimens by means of immunohistology
and electron microscopy.
Results
The 18 cases exhaustively investi-gated from the beginning consisted
of: 3 fibrosarcomas, 4 leiomyosarcomas, 2 rhab-domyosarcomas,
3 liposarcomas, 4 monophasic synovial sarcomas, 1 malignant pe-ripheral
nerve sheet tumor, and 1 myoftbrosarcoma. The final diagnosesalong
with the comparison with the original onesin the other 16
cases are reported in Table I.
Table I. Comparison between
original diagnosis (lines) and final diagnosis (columns)
|
|
FS |
MFS |
LMS |
LPS |
SS |
|
FS |
- |
- |
- |
- |
1 |
|
MFH |
2 |
3 |
4 |
3 |
- |
|
LPS |
- |
2 |
- |
- |
- |
|
MPNST |
- |
1 |
- |
- |
- |
FS: fibrosarcoma, MFH: malignant fibrous histiocytoma, MFS: myofibrosarcoma,
LMS: leiomyosarcoma, LPS: liposarcoma, MPNST: malignant peripheral
nerve sheath tumor, SS: monophasic synovial sarcoma.
In no case, after immunohistochemistry
and electron microscopy, was the original diag-nosis confirmed,
especially for malignant fibrous histiocytoma.
The more salient submicroscopic features
of the tumors investigated are synopti-cally summarized in Table
II, and the immunohistochemical data in Table III.
Table II. Salient submicroscopic features
(%) according to the histotype
|
|
FS
(N=5) |
MFS
(N=7) |
LMS
(N=8) |
RMS
(N=2) |
LPS
(N=6) |
MPNST (N=1) |
SS
(N=5) |
|
Feature |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
|
RER |
60.0 |
40.0 |
57.1 |
42.9 |
37.5 |
- |
50.0 |
50.0 |
33.3 |
66.7 |
100 |
- |
40.0 |
- |
|
Lipid vacuoles |
40.0 |
- |
28.6 |
- |
12.5 |
- |
50.0 |
- |
- |
100 |
- |
- |
- |
- |
|
Glycogen |
- |
- |
14.3 |
- |
12.5 |
- |
- |
- |
- |
16.7 |
- |
- |
- |
- |
|
Intermediate filaments |
40.0 |
- |
71.4 |
- |
50.0 |
- |
100 |
- |
33.3 |
- |
100 |
- |
40.0 |
40.0 |
|
Thin filaments |
- |
- |
42.9 |
57.1 |
25.0 |
75.0 |
- |
50.0 |
- |
- |
- |
- |
- |
- |
|
Sarcomeres |
- |
- |
- |
- |
- |
- |
50.0 |
50.0 |
- |
- |
- |
- |
- |
- |
|
Micropinocytotic vesicles |
20.0 |
- |
71.4 |
- |
25.0 |
37.5 |
100 |
- |
- |
- |
- |
- |
20.0 |
- |
|
Cell junctions |
60.0 |
- |
57.1 |
28.6 |
62.5 |
12.5 |
50.0 |
- |
33.3 |
- |
- |
- |
20.0 |
80.0 |
|
Basal lamina |
20.0 |
- |
71.4 |
- |
37.5 |
37.5 |
50.0 |
- |
83.3 |
16.7 |
- |
- |
60.0 |
- |
|
Fibronexa |
- |
- |
14.3 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Luse bodies |
- |
- |
- |
- |
12.5 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
FS: fibrosarcoma, MFS:
myofibrosarcoma, LMS: leiomyosarcoma, RMS, rhabdomyosarcoma, LPS:
liposarcoma, MPNST: malignant peripheral nerve sheath tumor, SS:
monophasic synovial sarcoma. +: Inconspicuous feature, ++: Prominent
feature
Table III. Results of the immunohistochemical
study (%) according to the histotype
|
|
FS
(N=5) |
MFS
(N=7) |
LMS
(N=8) |
RMS
(N=2) |
LPS
(N=6) |
MPNST (N=1) |
SS
(N=5) |
|
Feature |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
+ |
++ |
|
Vimentin |
20.0 |
80.0 |
28.6 |
71.4 |
12.5 |
87.5 |
- |
100 |
50.0 |
50.0 |
- |
100 |
20.0 |
80.0 |
|
S100-protein |
- |
- |
14.3 |
- |
- |
- |
- |
- |
16.7 |
- |
- |
100 |
40.0 |
- |
|
Muscle specific actin |
- |
- |
57.1 |
28.6 |
37.5 |
62.5 |
50.0 |
50.0 |
- |
- |
- |
- |
- |
- |
|
alpha-smooth muscle actin |
- |
- |
- |
- |
25.0 |
62.5 |
100 |
- |
- |
- |
- |
- |
- |
- |
|
Desmin |
- |
- |
- |
- |
12.5 |
- |
50.0 |
- |
- |
- |
- |
- |
- |
- |
|
Myoglobin |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
CD68 |
20.0 |
- |
- |
- |
- |
- |
- |
- |
50.0 |
16.7 |
- |
- |
- |
- |
|
CD34 |
- |
- |
14.3 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Collagen IV |
- |
- |
14.3 |
14.3 |
12.5 |
25.0 |
- |
- |
16.7 |
- |
- |
- |
20.0 |
- |
|
Laminin |
- |
- |
- |
- |
- |
- |
- |
- |
16.7 |
- |
- |
- |
- |
- |
|
Fibronectin |
- |
- |
28.6 |
28.6 |
12.5 |
25.0 |
- |
- |
16.7 |
16.7 |
- |
- |
20.0 |
- |
|
Cytokeratins |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
40.0 |
- |
|
EMA |
- |
- |
- |
- |
12.5 |
- |
- |
- |
- |
- |
- |
- |
40.0 |
40.0 |
FS: fibrosarcoma, MFS:
myofibrosarcoma, LMS: leiomyosarcoma, RMS, rhabdomyosarcoma, LPS:
liposarcoma, MPNST: malignant peripheral nerve sheath tumor, SS:
monophasic synovial sarcoma. +: Focal positivity (<20% of tumor
cells, ++: Diffuse positivity (>20% of tumor cells)
Comment
Our study clearly documented that ancillary techniques are mandatory
in order to properly identify poorly differentiated, spindle cell
and pleomorphic soft tissue sarcomas. In fact, in none of the
cases seen in consultation, in which we were initially unable
to perform electron microscopy and/or immunohistochemistry, the
diagnosis originally madeas a rule, in the absence of definite
criteria against the proffered diagnosis usually confirming the
diagnosis of the referring pathologistwas confirmed upon
the more accurate investi-gation using electron microscopy and
immunohistochemistry. Notably, malignant fibrous histiocytoma,
that was the most represented entity in this series (12 out of
16 cases), does not withstand the categorical scrutiny of electron
microscopy and immunohistology, and those cases were reclassified
by such means as poorly differentiated examples of fibro-sarcoma,
myofibrosarcoma, Ieiomyosarcoma, and liposarcoma.
In our experience, the immunohistochemical analysis does not quite
often give clear-cut information concerning the tumor cell phenotype,
when dealing with poorly differ-entiated spindle cell and pleomorphic
soft tissue sarcomas, and therefore is less valuable than electron
microscopy in typing these tumors, as opposed to what generally
considered on the basis of the everyday practice when more often
dealing with well and moderately differentiated soft tissue sarcomas.
In particular, in our series cytokeratins were documented to be
specific for synovial sarcoma, although the sensitivity was low.
Conversely, epithelial membrane antigen (EMA) was more sensitive
but, unfortunately, not completely specific. Markers identifying
contrac-tile filament peptides were restricted to specific tumor
categoriesspecifically, myofibro-sarcoma, Ieiomyosarcoma,
and rhabdomyosarcomabut did not allow a discrimination among
them even though, in our experience, a-smooth muscle actin was
never docu-mented in myofibrosarcoma. S-ICC protein was present
in several tumor types, even though was diffusely expressed only
in the only malignant peripheral nerve sheet tumor case. Similarly,
CD68, despite not specific, was consistently expressed by Iiposarcomas
only in our series. Laminin, fibronectin, and collagen type IV
were inconsistently seen, with a predilection for myofibrosarcoma,
Ieiomyosarcoma, liposarcoma, and synovial sarcoma.
Concerning electron microscopy, only the presence of rudimentary
sarcomeres was found to be specific and sensitive for rhabdomyosarcoma;
while the presence of fibronexa, despite considered specific of
myofibrosarcoma, was documented only in one such a case. Moreover,
electron microscopy was most valuable in sampling out liposarcoma,
due to the identification of multiple cytoplasmic lipid vacuoles
in a significant number of tumor cells. In addition, the combined
evaluation of different submicroscopic features in the sin-gle
case (R.E.R., intermediate filaments, thin filaments, micropinocytotic
vesicles, cell junctions, basal lamina, fibronexa) allowed the
differential diagnosis between fibrosar-coma, myofibrosarcoma,
Ieiomyosarcoma, malignant peripheral nerve sheet tumor, and monophasic
synovial sarcoma.
In conclusion, the combined use of electron microscopy and immunohistochemistry
can allow a proper categorization of poorly differentiated, spindle
cell and pleomorphic soft tissue sarcomas in virtually all cases.
References
- Erlandson RA. Diagnostic
Transmission Electron Microscopy of Tumors with Clini-copathological,
lmmunohistochemical, and Cytogenetic Correlations. Raven Press,
1994.
- Eyden BP, Christensen
L. Leiomyosarcoma versus myofibrosarcoma: Observations and terminology.
Ultrastruot Pathol 1993: 17; 231-239.
- Fisher C. The value of
electron microscopy and immunohistochemistry in the diagnosis
of soft tissue sarcomas: A study of 200 cases. Histopathology
1990: 16; 441-454.
- Fletcher CDM. Pleomorphic
malignant fibrous histiocytoma: Fact or fiction? A critical reappraisal
based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg
Pathol 1992:16; 21 3-228.
- Leong A S-Y, Wick MR,
Swanson PE. lmmunohistology and electron microscopy of anaplastic
and pleomorphic tumors. Cambridge University Press, I 997.
- Schurch W, Begin LR, Seemayer
TA, et al. Pleomorphic soft tissue myogenic sarco-mas of adulthood:
A reappraisal in the mid-1990s. Am J Surg Pathol 1996: 20: 131-
147.
- Wick MR, Swanson PE, Manivel
JC. lmmunohistochemical analysis of soft tissue sar-comas: Comparison
with electron microscopy. Appl Pathol 1988: 6; 169-196.
